HomeAPTO • NASDAQ
add
Aptose Biosciences Inc
Previous close
$1.26
Day range
$1.25 - $1.29
Year range
$1.20 - $8.70
Market cap
20.05M USD
Avg Volume
78.90K
P/E ratio
-
Dividend yield
-
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 12.13M | 16.57% |
Net income | -11.96M | -19.55% |
Net profit margin | — | — |
Earnings per share | -1.95 | 13.29% |
EBITDA | -12.11M | -16.71% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 9.25M | -80.30% |
Total assets | 12.99M | -74.54% |
Total liabilities | 15.89M | 19.60% |
Total equity | -2.90M | — |
Shares outstanding | 15.72M | — |
Price to book | -3.41 | — |
Return on assets | -179.05% | — |
Return on capital | -866.21% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -11.96M | -19.55% |
Cash from operations | -9.26M | -7.03% |
Cash from investing | 1.94M | -88.97% |
Cash from financing | 854.00K | 1,574.51% |
Net change in cash | -6.47M | -172.03% |
Free cash flow | -4.86M | 0.72% |
About
Founded
1986
Headquarters
Website
Employees
36